Article Details
Retrieved on: 2021-06-30 06:33:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Remdesivir (FDA-approved for use in COVID-19) and Molnupirivir (in clinical trial) are misincorporated by the viral RdRp leading to delayed chain ...
Article found on: www.news-medical.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here